No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls

scientific article published on March 2009

No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/13547500902783739
P8608Fatcat IDrelease_qdrhemftazbv3jr7ae4ggg45ca
P932PMC publication ID4415987
P698PubMed publication ID19330584

P50authorPhilippe GrandjeanQ16145198
Teresa CocciniQ53127233
P2093author name stringPal Weihe
Luigi Manzo
Ulrike Steuerwald
Frodi Debes
P2860cites workIn vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agentsQ23917153
Umbilical cord mercury concentration as biomarker of prenatal exposure to methylmercuryQ24813643
Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to SchizophreniaQ28244485
The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identicalQ28270262
Association between the CHRM2 gene and intelligence in a sample of 304 Dutch familiesQ28271932
Developmental neurotoxicity of industrial chemicalsQ28279457
Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or BQ28366805
Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in ratsQ48336459
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognitionQ48430459
Methylmercury interaction with lymphocyte cholinergic muscarinic receptors in developing rats.Q48483350
Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercuryQ48492467
Relationship between platelet monoamine oxidase-B (MAO-B) activity and mercury exposure in fish consumers from the Lake St. Pierre region of Que., CanadaQ48640626
Interaction of mercury compounds with muscarinic receptor subtypes in the rat brainQ48894311
Pathological gambling and platelet MAO activity: a psychobiological study.Q51046522
Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology.Q51977326
Cognitive development in preschool children prenatally exposed to PCBs and MeHg.Q52020776
Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia.Q52068277
Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders?Q52098285
Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder.Q53572234
Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.Q53920138
Muscarinic Acetylcholine Receptors on Human Lymphocytes in Patients with Meniere's DiseaseQ58272674
Platelet monoamine oxidase activity in obsessive-compulsive disorderQ60366398
Changes of muscarinic cholinergic binding by lymphocytes in parkinson's disease with and without dementiaQ67856020
Effect of PCB and DES on rat monoamine oxidase, acetylcholinesterase, testosterone, and estradiol ontogenyQ68100195
Decreased platelet monoamine oxidase activity in female bulimia nervosaQ73521205
Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorderQ74599885
Brain monoaminergic neurotransmission parameters in weanling rats after perinatal exposure to methylmercury and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153)Q28567869
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal modelsQ29547388
Cognitive deficit in 7-year-old children with prenatal exposure to methylmercuryQ29615556
Neurodevelopmental toxicity of methylmercury: Laboratory animal data and their contribution to human risk assessmentQ31155504
Assessing effects of neurotoxic pollutants by biochemical markersQ31848578
Attention and executive deficits in Alzheimer's disease. A critical reviewQ33545617
Human platelet monoamine oxidase activity in health and disease: a reviewQ33848742
Maternal seafood diet, methylmercury exposure, and neonatal neurologic functionQ33901206
Association of CHRM2 with IQ: converging evidence for a gene influencing intelligenceQ34589759
Neonatal exposure to 3,3',4,4'-tetrachlorobiphenyl: changes in spontaneous behaviour and cholinergic muscarinic receptors in the adult mouseQ34956636
A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injuryQ35056196
Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoringQ35134674
Monoamine oxidase-B inhibition in Alzheimer's diseaseQ35617449
Disruption of intraneuronal divalent cation regulation by methylmercury: are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning?Q35853203
Neurobehavioural and molecular changes induced by methylmercury exposure during developmentQ36797999
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug developmentQ36925551
Human developmental neurotoxicity of methylmercury: impact of variables and risk modifiersQ37119494
Platelet monoamine oxidase B activity in workers exposed to styreneQ38532677
Vulnerable periods and processes during central nervous system developmentQ40632179
Biochemical markers of neurotoxicity. A review of mechanistic studies and applicationsQ41178207
Teratogen update: polychlorinated biphenylsQ41568830
Lymphocyte muscarinic receptors and platelet monoamine oxidase-B as biomarkers of CNS function: effects of age and gender in healthy humansQ42491975
Platelet serotonin concentrations in medicated schizophrenic patientsQ42507013
Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction?Q43813971
Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice.Q43833022
Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurementsQ44096219
Platelet MAO in subtypes of alcoholismQ44123428
Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender.Q44203714
The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression.Q44638219
Decreased (3H) quinuclidinyl benzilate binding to lymphocytes in Gilles de la Tourette syndrome.Q46018390
Platelet monoamine oxidase activity levels in subgroups of alcoholics: diagnostic, temporal, and clinical correlatesQ46078104
An interspecies comparison of mercury inhibition on muscarinic acetylcholine receptor binding in the cerebral cortex and cerebellumQ46483179
Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactionsQ46502417
Platelet monoamine oxidase B (MAO-B) activity and its relationship to DL-fenfluramine-induced prolactin response in healthy men.Q46549768
Neurobehavioral deficits associated with PCB in 7-year-old children prenatally exposed to seafood neurotoxicantsQ46697263
Effects of developmental co-exposure to methylmercury and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) on cholinergic muscarinic receptors in rat brainQ46925087
Effects of prenatal methylmercury exposure on brain monoamine oxidase activity and neurobehaviour of ratsQ46953943
Chronic L-deprenyl or L-amphetamine: equal cognitive enhancement, unequal MAO inhibitionQ47634252
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytesQ48099696
Perinatal co-exposure to methylmercury and PCB153 or PCB126 in rats alters the cerebral cholinergic muscarinic receptors at weaning and puberty.Q48111814
Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 yearsQ48148022
Monoamine oxidases: activities, genotypes and the shaping of behaviourQ48208271
Disruption by methylmercury of membrane excitability and synaptic transmission of CA1 neurons in hippocampal slices of the rat.Q48269671
Substrate- and inhibitor-related characteristics of human platelet monoamine oxidaseQ48295329
P433issue2
P921main subjectFaroe IslandsQ4628
polychlorinated biphenylQ211171
biomarkerQ864574
P304page(s)67-76
P577publication date2009-03-01
P1433published inBiomarkersQ4915076
P1476titleNo changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls
P478volume14

Reverse relations

cites work (P2860)
Q28397719Application of Neurochemical Markers for Assessing Health Effects after Developmental Methylmercury and PCB Coexposure
Q23916607Metrological assessment of a portable analyzer for monitoring the particle size distribution of ultrafine particles
Q46492710Platelet oxygen consumption as a peripheral blood marker of brain energetics in a mouse model of severe neurotoxicity
Q38092557Systematic analysis of the relationship between standardized prenatal exposure to polychlorinated biphenyls and mental and motor development during follow-up of nine children cohorts

Search more.